![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 12, 8760-8765, March 24, 2000
From the Division of Biological Sciences, Institute of Scientific
and Industrial Research, Osaka University, Core Research for
Evolutional Science and Technology (CREST) of the Japan Science and
Technology Corporation, Osaka 567-0047, Japan
Vacuolar H+-ATPase (V-ATPase)
is a multi-subunit enzyme with a membrane peripheral catalytic
(V1) and an intrinsic (Vo) sector. We have
identified three cDNA clones coding for isoforms of mouse Vo subunit a (a1, a2,
and a3). They exhibit 48-52% identity with each other and
high similarity to subunit a of other species. The
a1 isoform was mainly expressed in brain and liver. The
a2 isoform was observed in heart and kidney in addition to
brain and liver. Transcripts for the a3 isoform were
strongly expressed in heart and liver. The a3 isoform was
induced during osteoclast differentiation, and localized in the plasma
membrane and cytoplasmic filamentous structures. In contrast to
a3, the a1 isoform was constitutively expressed
and localized in the cytoplasmic endomembrane compartments of the same
cells. These findings suggest that the a3 isoform is a
component of the plasma membrane V-ATPase essential for bone resorption.
The acidification of intracellular compartments is driven by a
vacuolar-type H+-ATPase
(V-ATPase)1 and is essential
for processes such as zymogen activation, protein sorting,
receptor-mediated endocytosis, and neurotransmitter uptake into
synaptic vesicles (1-4). V-ATPases are also localized in the plasma
membranes of epithelial cells of tissues such as kidney, seminal duct,
and bladder (5-7). V-ATPase localized in the ruffled border membranes
of osteoclasts secretes protons to dissolve mineral components of bones
for remodeling (8, 9). A ring of actin filaments bound to the ruffled
membrane restricts the cell surface region attached to the bone (10,
11). Recent studies suggested that V-ATPase is associated with the
cytoskeleton including actin filaments (12, 13).
V-ATPase is a complex of at least 13 different subunits forming two
functional sectors, V1 and Vo (1). The
V1 sector consisting of eight subunits
(A-H) has three catalytic sites at the interface between the A and B subunits, similar to ATP
synthase (F1Fo) (14), whereas the
Vo sector (a, c, c',
c", and d) forms a proton pathway. Although
subunit a, also called the 116-kDa subunit, is a major component of the Vo sector, its function remains unknown.
Yeast has two different forms of subunit a, Vph1p and Stv1p
(15, 16). Proteolipid subunits (c, c', and
c") are thought to be directly involved in proton
translocation. Recent studies indicated that subunit c
isoforms are present in several species (17-24). Isoforms of other
subunits have also been found in vertebrates (25-34). Mutations of the
gene for one of the two B subunits (B1) cause renal tubular acidosis with sensorineural deafness in humans (35). However, the roles of other subunit isoforms have not been clearly defined. The divergence of the subunits may be responsible for the
regulation of enzyme activity and/or its localization in specific tissues or subcellular compartments.
In this study, three cDNA clones coding for mouse subunit
a were identified and their gene products were designated as
a1, a2, and a3. They exhibit 48-52%
sequence identity with each other and high similarity with the
corresponding subunits of other vertebrates. One of them, the
a3 subunit, was induced during osteoclast differentiation, and localized in the plasma membrane, whereas a1 was
distributed in the dot-like structures, presumably endomembrane
organelles, in osteoclasts. These results suggest that a3 is
a key subunit of V-ATPase for its localization in the plasma membranes
of osteoclasts, and thus for bone resorption.
Materials--
A SuperscriptTM mouse 13.5 day embryo cDNA
library (SuperscriptTM), Cloning of Subunit a Isoforms--
One mouse EST clone
(AA444415) was prepared and sequenced using a model 377 DNA sequencer
(Applied Biosystem). Since the cDNA lacked the 5' region, a mouse
embryo cDNA library was screened to isolate a full-length clone. On
screening (1 × 107 colonies), a single clone was
isolated and sequenced. The clone contained a full-length cDNA,
although two introns (79 and 308 bp) were present in the open reading
frame. To remove these introns, a DNA fragment was amplified by reverse
transcribed PCR using mRNA prepared from 13.5-day mouse embryos,
and then cloned. The resulting product was introduced into the
corresponding region of the cDNA clone to construct a complete
cDNA coding for the a3 isoform.
Mouse EST clones (AA980626 and AA611922, coding for the a1
and a2 isoforms, respectively) were sequenced. The 5' region of each clone was obtained by 5'-RACE using mRNA from 13.5-day mouse embryos. The PCR products were sequenced and ligated with the
corresponding cDNAs to create full-length clones for a1
and a2. The entire cDNAs for a1,
a2, and a3 were 3815, 2917, and 2587 bp (not
including polyadenylation), respectively.
Northern Blot--
Northern blot analysis was carried out using
multiple tissue blots (CLONTECH) according to the
manufacturer's recommendations. Each probe was prepared from a
cDNA clone (a1, +851 to +1286 bp; a2, Genomic Southern Blot--
Genomic DNA (10 µg) from 129/Sv
mice was digested with restriction enzymes, electrophoresed on an
agarose gel, and then blotted onto a filter. Radioactive probes were
prepared from cDNA clones (a1, +847 to +1310 bp;
a2, Preparation of Antibodies against Subunit a
Isoforms--
Synthetic peptides (a1, RRCEEMDRKLRFVEKEI,
positions 56-72; and a3, HRHRRNTQRRPAGQQDE, positions
660-676) were used to raise isoform-specific antibodies. The
antibodies were purified using a recombinant protein-conjugated
affinity columns, HiTrap® (Amersham Pharmacia Biotech).
Anti-a2 antiserum was generated by immunizing rabbits with a
recombinant protein including a part of a2 (615-742
residues), and affinity-purified using the same protein.
Culture of Mouse Bone Marrow Cells--
Osteoclasts were
generated from a mouse bone marrow cell culture (36). After sacrifice
by cervical dislocation, the tibiae of ddY male mice were aseptically
removed and dissected free of adhering tissues. The bone ends were cut
off, and the marrow cells were flushed out with Western Blot--
Cells were solubilized in 50 mM
Tris-HCl buffer (pH 6.8) containing 10% glycerol and 2% SDS, and then
heated at 60 °C for 5 min. Samples were separated by polyacrylamide
gel electrophoresis in the presence of the same detergent and then
transferred electrophoretically to nitrocellulose membranes.
Immunodetection was carried out using alkaline phosphatase-conjugated
antibodies, 5-bromo-4-chloro-3-indolyl phosphate and 4-nitro blue
tetrazolium chloride.
Immunofluorescence Microscopy--
Cells were fixed for 25 min
with 2% paraformaldehyde in 0.2 M sodium phosphate buffer
(pH 7.0) at room temperature, and then rinsed with the same buffer
containing 0.1 M glycine. Following the fixation, the cells
were soaked with a permeabilization solution (0.4% saponin, 1% bovine
serum albumin, and 2% normal goat serum in phosphate-buffered saline)
for 15 min at room temperature, and then incubated for 60 min with
the antibodies against subunit a and washed with the same
solution. They were incubated with fluorescein
isothiocyanate-conjugated antibodies (Jackson Immunoresearch Laboratories Inc.) for 60 min, washed with the same solution, and then
mounted with Vector Shield (Vector Laboratories). Fluorescence images
were acquired using LSM 510 (Carl Zeiss).
Identification of Three Mouse cDNA Clones for V-ATPase Subunit
a Isoforms--
A search of mouse EST data bases using the amino acid
sequence of bovine subunit a (30) led to the identification
of three clones (AA980626, AA611922, and AA444415) that could code
partial sequences of proteins similar to the subunit a of other species. Since one EST clone (AA444415) lacked the 5' region, we
searched a mouse cDNA library and obtained one full-length clone
corresponding to the EST. For the other two clones (AA980626 and
AA611922), 5'-RACE was carried out using 13.5-day embryo mRNA, and
full-length cDNAs were constructed from the PCR products and the
corresponding clones. Based on the similarity with the subunit
a of other species (see below), the proteins encoded by the
cDNAs were named the a1, a2, and
a3 subunits (Fig. 1).
Amino Acid Sequences and Transmembrane Structures of Subunit a
Isoforms--
The a1, a2, and a3
isoforms comprised 832, 856, and 834 amino acid residues, respectively.
Hydropathy plot analysis (38) indicated that these isoforms had closely
similar structures with nine putative transmembrane regions (Fig. 1,
I-IX), as proposed by Leng et al. (39). Higher
conservation was observed in the putative transmembrane regions. The
a1 and a2 isoforms had single potential
N-linked glycosylation sites at positions 489 and 505, respectively, whereas the a3 isoform contained three sites
at positions 484, 504, and 595 (Fig. 1, shaded boxes). The
a1, a2, and a3 isoforms exhibited
48-52% identity with each other. The a1 isoform showed 95 and 99% identity to the subunit a of bovine and rat
clathrin-coated vesicles, respectively (30, 40). The a2
isoform was identical to a putative immunoregulatory protein from mouse
T cells (25) except for a replacement (Ser Tissue Distributions of Subunit a Isoforms--
Northern blot
analysis revealed that a 4.2-kb a1 transcript was present in
all tissues examined (Fig. 2). High
levels of expression were observed in brain and liver, as previously
reported (30, 40). Expression of the a2 transcript was
detectable in heart, brain, liver, and kidney. The a3
transcript was observed predominantly in heart and liver. Low but
significant expression of the a3 isoform was found in brain,
spleen, lung, and kidney. Transcripts of different sizes, possibly due
to alternative splicing, were detected for the a2 and
a3 isoforms: a2, 2.6, 3.0, and 4.9 kb;
a3, 2.5 and 3.2 kb. We identified an EST clone (AA591593)
for the a2 isoform, containing an additional 599-bp 3'
untranslational region, presumably corresponding to the splicing
variant of the EST clone described above.
Southern blot analysis of mouse genomic DNA indicated that a single
gene for the a3 isoform was present in the mouse genome (Fig. 3). The genomic DNAs for the
a1 and a2 isoforms gave more than one band
depending on the endonucleases used, suggesting that there may be
related sequences in the genome.
Induction of the a3 Isoform during Osteoclast
Differentiation--
In osteoclasts, V-ATPase is distributed in the
ruffled border membrane and acidifies the outside for bone resorption
(8, 9). Thus, it became of interest to determine which isoform(s) was
expressed in the plasma membrane of osteoclasts. Mouse bone marrow
cells were cultured in the presence of 1,25(OH)2
D3 to develop osteoclasts in vitro (36). As
shown in Fig. 4A, the a3 isoform was strongly expressed in the presence of
1,25(OH)2 D3. In contrast to a3, the
a1 and a2 isoforms were constitutively synthesized regardless of the presence of 1,25(OH)2
D3; low but significant signals were observed for both
isoforms. The time course of the appearance of the a3
isoform expression was consistent with the profile of osteoclast
differentiation (Fig. 4B). These results indicated that only
the a3 isoform was induced during osteoclast
differentiation. Consistent with the increase in the a3
isoform in the Vo sector, the A and B
subunits in the V1 sector were also induced on the addition
of 1,25(OH)2 D3 (Fig. 4A),
suggesting that the entire V-ATPase was induced during osteoclast
differentiation.
Presence of the a3 Isoform in the Osteoclast Plasma
Membrane--
V-ATPases related to bone resorption should be localized
in the plasma membrane to acidify the resorption lacuna. The
intracellular distributions of the a1, a2, and
a3 isoforms were determined by immunofluorescence microscopy
using affinity-purified antibodies. The a1 isoform was found
in the dot-like structures dispersed throughout the cytoplasm (Fig.
5, A and B),
whereas the signal of the a3 isoform was detected on the
plasma membrane and its vicinity (Fig. 5, C and
D). No signals were detected with the anti-a2
antibodies, probably due to the low level of a2 expression in osteoclasts (Fig. 4A). Consistent with the induction of
subunit A and B of V1 sector in the
presence of 1,25(OH)2 D3, they were also
detectable in the osteoclast plasma membrane (data not shown). These
results indicated that the a3 isoform was predominantly located in the plasma membrane, and thus is a component of the V-ATPase
responsible for bone resorption in osteoclasts.
Lee et al. recently reported that V-ATPase subunit
E is co-localized with actin filaments in osteoclasts (13).
The a3 isoform was also observed on the filamentous
structures extending from the plasma membrane (Fig.
6, A and D). It was
of interest to identify the filamentous structures. Actin filaments
along the ruffled membrane were observed, as reported previously (10,
11). However, the filamentous structures stained with antibodies
against the a3 isoform were different from actin filaments
(Fig. 6, A-C). In contrast to actin filaments, microtubules
were co-localized significantly with the filamentous structures (Fig.
6, D-F). These results indicated that the a3
isoform was associated with microtubules in osteoclasts.
We have identified three cDNA clones coding for the
a1, a2, and a3 isoforms of mouse
V-ATPase subunit a. They were expressed differently in the
mouse tissues examined. The a1 isoform was mainly expressed
in brain and exhibited high identity with subunit a from
clathrin-coated vesicles of rat and bovine brain (30, 40). The
a2 isoform exhibited 91% identity to the subunit
a purified from bovine lung (34), although no a2
expression was detectable in mouse lung on Northern blotting. High
levels of a3 expression were observed in brain and liver. It
is tempting to assume that the different expression patterns of the
isoforms are responsible for the diverse functions of V-ATPases in
these tissues. The a1 and a2 isoforms contained
one putative N-linked glycosylation site, whereas
a3 had three sites. Consistent with these numbers of sites,
the a3 isoform from mouse tissues migrated slower than the
a1 and a2 ones on polyacrylamide gel
electrophoresis.2
Yeast cells have two subunit a isoforms (Vph1p and Stv1p)
(15, 16). Vph1p, the major form of subunit a, is localized
in the vacuolar membrane, whereas Stv1p is located in the Golgi or endosomal membrane (16), suggesting that subunit a plays a
functional role in targeting V-ATPases to their resident compartments.
To determine which mouse isoform corresponds to Vph1p or Stv1p,
expression plasmid carrying cDNA for the mouse a1,
a2, or a3 isoform was introduced into the
vph1 and stv1 mutant cells. However, no clones could complement the vph1 and stv1 mutations.
These results are not surprising because the amino acid identities
between Vph1p (or Stv1p) and mouse a isoforms are not high
(36-40%).
Isoforms of V-ATPase subunit A, B, G,
H, and a have been identified in vertebrates
(25-27, 29-34). Mouse a subunits are the first example of
all three isoforms being identified in the same higher eukaryote.
Northern blot analysis revealed three transcripts for the a2
subunit and two for a3, possibly due to alternative splicing. These transcripts may cause further variation of subunit a. This variety of isoform combinations is enough to create
the diversity of V-ATPases, which may establish different pH in acidic compartments. The different subunits may also contribute to the subcellular localization of the entire enzyme.
In osteoclasts, the B2 isoform is known to be specifically
expressed and distributed in the plasma membrane (41, 42). Furthermore,
the isoform was reported to be induced in osteoclasts generated from
human blood monocytes (43). The a1, a2, and
a3 isoforms were synthesized in osteoclasts, but only
a3 was induced specifically and localized in the plasma
membrane, suggesting that the V-ATPase subtype having the B2
and a3 isoforms is an inducible complex involved in bone
resorption of osteoclasts. It is of interest to study the intracellular
locations of the a3 isoform in heart and liver, where the
a3 transcripts are predominantly expressed. The
a2 isoform was expressed in thymus (25), implying that this
isoform may be a component of the V-ATPase subtype related to immune responses.
Lee et al. (13) recently showed that subunit E of
V-ATPase is co-localized and associated with actin filaments,
suggesting that V-ATPase interacts with actin filaments during
osteoclast activation. However, immunofluorescence analysis revealed
that the filamentous structures of the a3 isoform staining
were co-localized with microtubules but not with actin filaments.
Treatment with cytochalasin D, an inhibitor of actin polymerization,
showed no effect on the localization of the a3 subunit.
However, no filamentous staining of the a3 isoform was
observed by treatment with nocodazole, which causes microtubule
depolymerization.2 These results suggest that the
a3 isoform is associated with microtubules. Subunit
A is co-localized with microtubules in avian osteoclast-like
cells (44). It is difficult to assume that subunit a alone
is transported from the endoplasmic reticulum without assembly as the
Vo sector, because subunit a, if not assembled into V-ATPase, is susceptible of proteolytic degradation (1). Thus,
V-ATPase (having the a3 isoform) in the transport vesicles may interact with microtubules and thereby be carried to the ruffled border membrane. In this regard, microtubules and microfilaments are
known to be important for the trafficking of transport vesicles to
their destinations (45).
We thank Dr. K. Kawashima (Teikyo University)
for helping us to establish the in vitro culture of osteoclasts.
*
This work was supported in part by a grant from the Ministry
of Education, Science and Culture of Japan.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AB022321 (a1), AB022323 (a2), and AB022322 (a3).
2
T. Toyomura, T. Oka, and M. Futai, unpublished results.
The abbreviations used are:
V-ATPase, vacuolar H+-ATPase;
EST, expressed sequence tag;
PCR, polymerase chain reaction;
RACE, rapid amplification of cDNA
ends;
1, 25(OH)2 D3, 1
Three Subunit a Isoforms of Mouse Vacuolar
H+-ATPase
PREFERENTIAL EXPRESSION OF THE a3 ISOFORM DURING
OSTEOCLAST DIFFERENTIATION*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-minimum essential medium (
-MEM), and
fetal bovine serum were purchased from Life Technologies, Inc.
Radioactive materials were from Amersham Pharmacia Biotech. Enzymes for
molecular cloning were from Takara Shuzo Co., Ltd. 1
,25-Dihydroxy
cholecalciferol (1,25(OH)2 D3) was from Sigma.
The ddY male mice were from Japan SLC Co., Ltd. Nitrocellulose
membranes were from Advantec. The mouse expressed sequence tag (EST)
clones were from Genome System Inc. and American Type Culture Collection.
2 to
+956 bp; and a3, +479 to +1161 bp; numbering from the first
letter of the initiation codon), and labeled with
[
-32P]dCTP using Ready-To-GoTM DNA labeling beads
(Amersham Pharmacia Biotech). Filter was hybridized with a probe using
ExpressHyb hybridization solution (CLONTECH) at
68 °C for 60 min. The radioactive filters were analyzed with
BAS-1000 (Fuji Film).
18 to +502 bp; and a3, +1721 to +2042 bp).
-MEM medium. These
cells were cultured at 2 × 106 cells/ml in
-MEM
containing 10% fetal bovine serum, and maintained by replacing the
medium every 2 days with new one containing 1,25(OH)2 D3 (5 × 10
8 M) at 37 °C
(5% CO2). Histochemical staining for tartrate-resistant acid phosphatase activity was performed to confirm the presence of
osteoclasts (36, 37).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (66K):
[in a new window]
Fig. 1.
Alignment of the amino acid sequences of
subunit a isoforms. The deduced amino acid
sequences of subunit a isoforms (a1,
a2, and a3) were aligned to obtain maximal
homology. Open and shaded boxes represent
identical residues in the three isoforms and putative
N-linked glycosylation sites (N-X-S/T),
respectively. Putative transmembrane domains (I-IX) were
defined by hydropathy analysis, and are similar to the topology model
of yeast subunit a (Vph1p) proposed by Leng et
al. (39).
Cys) at position 486 and
a Leu insertion at position 788 in the a2 isoform. This
difference may be due to the mouse strains used for cloning. The
a2 isoform exhibited 91% identity with the subunit a purified from bovine lung (34). The a3 isoform
showed 84% identity with the polypeptide encoded by OC-116-kDa from a
human osteoclastoma (31).

View larger version (74K):
[in a new window]
Fig. 2.
Northern blot analysis of subunit
a isoforms. Poly(A+) RNAs (2 µg)
from heart, brain, spleen, lung, liver, skeletal muscle, kidney, and
testis were subjected to electrophoresis, blotted onto a filter, and
then hybridized with radioactive probes of the indicated isoforms. The
blot was also hybridized with a control probe of human
-actin.
Arrowheads indicate the positions of the transcripts.

View larger version (61K):
[in a new window]
Fig. 3.
Genomic Southern blot analysis of subunit
a isoforms. Mouse genomic DNA (10 µg) was
digested with BamHI (lane 1),
BglII (lane 2), EcoRI
(lane 3), EcoRV (lane
4), HincII (lane 5),
HindIII (lane 6), PstI
(lane 7), PvuII (lane
8), or XbaI (lane 9), and
then electrophoresed on an agarose gel. After blotting, the filter was
hybridized with radioactive probes of the indicated isoforms.

View larger version (33K):
[in a new window]
Fig. 4.
Expression of subunit a
isoforms during osteoclast differentiation. A,
bone marrow cells were cultured for 7 days in the presence (+) or
absence (
) of 1,25(OH)2 D3. Total cell
proteins (7 µg) were separated by gel electrophoresis and then
incubated with antibod- ies against a1, a2, or a3, or
ones against subunit A (A). Expression of subunit
B was essentially the same as that of subunit A
(see Footnote 2). B, bone marrow cells were cultured for the
indicated numbers of days in the presence of 1,25(OH)2
D3. Cells were subjected to tartrate-resistant acid
phosphatase staining to determine the numbers of osteoclasts
(OC). Cell nuclei were visualized by staining with methyl
green. Scale bar indicates 200 µm. Total
proteins (3 µg) were electrophoresed and blotted onto a filter. The
immunoblot filter was analyzed by densitometry, and the amounts of the
a3 isoform were estimated.

View larger version (126K):
[in a new window]
Fig. 5.
Immunofluorescence analysis of the
a1 and a3 isoforms in
osteoclasts. After fixing with paraformaldehyde, cells were
permeabilized and incubated with antibodies against a1
(A) or a3 (C), followed by fluorescein
isothiocyanate-conjugated antibodies. Osteoclasts were identified as
multi-nuclear cells exhibiting tartrate-resistant acid phosphatase
staining. B and D are phase contrast images
corresponding to A and C, respectively. The
confocal images are of 8-µm sections. Scale
bars indicate 50 µm.

View larger version (66K):
[in a new window]
Fig. 6.
Co-localization of the a3
isoform with microtubules. Cells were fixed and permeabilized,
followed by staining with either rhodamine-phalloidin (B) or
anti-tubulin antibodies, YOL1/34 (E), together with
antibodies against a3 (A and D).
C and F represent merged images. The confocal
images are of 1-µm sections. Scale bars
indicate 20 µm.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
ACKNOWLEDGEMENT
![]()
FOOTNOTES
To whom correspondence should be addressed. Tel.: 81-6-6879-8480;
Fax: 81-6-6875-5724; E-mail: m-futai@sanken.osaka-u.ac.jp.
![]()
ABBREVIATIONS
,25-dihydroxy
cholecalciferol;
bp, base pair(s);
kb, kilobase pair(s);
-MEM,
-minimal essential medium.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Stevens, T. H.,
and Forgac, M.
(1997)
Annu. Rev. Cell Dev. Biol.
13,
779-808[CrossRef][Medline]
[Order article via Infotrieve]
2.
Anraku, Y.
(1996)
in
Handbook of Biological Physics
(Konings, W. N.
, Kaback, H. R.
, and Lolkema, J. S., eds), Vol. 2
, pp. 93-109, Elsevier Science Publishing Co., Inc., New York
3.
Futai, M.,
Oka, T.,
Moriyama, Y.,
and Wada, Y.
(1998)
J. Biochem. (Tokyo)
124,
259-267 4.
Nelson, N.,
and Harvey, W. R.
(1999)
Physiol. Rev.
79,
361-385 5.
Brown, D.,
and Breton, S.
(1996)
J. Exp. Biol.
199,
2345-2358[Abstract]
6.
Brown, D.,
Smith, P. J.,
and Breton, S.
(1997)
J. Exp. Biol.
200,
257-262[Abstract]
7.
Tomochika, K.,
Shinoda, S.,
Kumon, H.,
Mori, M.,
Moriyama, Y.,
and Futai, M.
(1997)
FEBS Lett.
404,
61-64[CrossRef][Medline]
[Order article via Infotrieve]
8.
Blair, H. C.,
Teitelbaum, S. L.,
Ghiselli, R.,
and Gluck, S.
(1989)
Science
245,
855-857 9.
Nakamura, H.,
Moriyama, Y.,
Futai, M.,
and Ozawa, H.
(1994)
Arch. Histol. Cytol.
57,
535-539[Medline]
[Order article via Infotrieve]
10.
Lakkakorpi, P. T.,
and Väänänen, H. K.
(1991)
J. Bone Miner. Res.
6,
817-826[Medline]
[Order article via Infotrieve]
11.
Turksen, K.,
Kanehisa, J.,
Opas, M.,
Heersche, J. N.,
and Aubin, J. E.
(1988)
J. Bone Miner. Res.
3,
389-400[Medline]
[Order article via Infotrieve]
12.
Nakamura, I.,
Takahashi, N.,
Udagawa, N.,
Moriyama, Y.,
Kurokawa, T.,
Jimi, E.,
Sasaki, T.,
and Suda, T.
(1997)
FEBS Lett.
401,
207-212[CrossRef][Medline]
[Order article via Infotrieve]
13.
Lee, B. S.,
Gluck, S. L.,
and Holliday, L. S.
(1999)
J. Biol. Chem.
274,
29164-29171 14.
Futai, M.,
and Omote, H.
(1996)
J. Bioenerg. Biomembr.
28,
409-414[CrossRef][Medline]
[Order article via Infotrieve]
15.
Manolson, M. F.,
Proteau, D.,
and Jones, E. W.
(1992)
J. Exp. Biol.
172,
105-112 16.
Manolson, M. F.,
Wu, B.,
Proteau, D.,
Taillon, B. E.,
Roberts, B. T.,
Hoyt, M. A.,
and Jones, E. W.
(1994)
J. Biol. Chem.
269,
14064-14074 17.
Oka, T.,
Yamamoto, R.,
and Futai, M.
(1997)
J. Biol. Chem.
272,
24387-24392 18.
Oka, T.,
Yamamoto, R.,
and Futai, M.
(1998)
J. Biol. Chem.
273,
22570-22576 19.
Umemoto, N.,
Yoshihisa, T.,
Hirata, R.,
and Anraku, Y.
(1990)
J. Biol. Chem.
265,
18447-18453 20.
Umemoto, N.,
Ohya, Y.,
and Anraku, Y.
(1991)
J. Biol. Chem.
266,
24526-24532 21.
Hirata, R.,
Graham, L. A.,
Takatsuki, A.,
Stevens, T. H.,
and Anraku, Y.
(1997)
J. Biol. Chem.
272,
4795-4803 22.
Hasebe, M.,
Hanada, H.,
Moriyama, Y.,
Maeda, M.,
and Futai, M.
(1992)
Biochem. Biophys. Res. Commun.
183,
856-863[CrossRef][Medline]
[Order article via Infotrieve]
23.
Hernando, N.,
Bartkiewicz, M.,
Collin-Osdoby, P.,
Osdoby, P.,
and Baron, R.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
6087-6091 24.
Hasenfratz, M. P.,
Tsou, C. L.,
and Wilkins, T. A.
(1995)
Plant Physiol.
108,
1395-1404[Abstract]
25.
Lee, C.,
Ghoshal, K.,
and Beaman, K. D.
(1990)
Mol. Immunol.
27,
1137-1144[CrossRef][Medline]
[Order article via Infotrieve]
26.
Puopolo, K.,
Kumamoto, C.,
Adachi, I.,
Magner, R.,
and Forgac, M.
(1992)
J. Biol. Chem.
267,
3696-3706 27.
Nelson, N.
(1992)
J. Bioenerg. Biomembr.
24,
407-414[CrossRef][Medline]
[Order article via Infotrieve]
28.
Hemken, P.,
Guo, X. L.,
Wang, Z. Q.,
Zhang, K.,
and Gluck, S.
(1992)
J. Biol. Chem.
267,
9948-9957 29.
van Hille, B.,
Richener, H.,
Evans, D. B.,
Green, J. R.,
and Bilbe, G.
(1993)
J. Biol. Chem.
268,
7075-7080 30.
Peng, S.-B.,
Crider, B. P.,
Xie, X.-S.,
and Stone, D. K.
(1994)
J. Biol. Chem.
269,
17262-17266 31.
Li, Y. P.,
Chen, W.,
and Stashenko, P.
(1996)
Biochem. Biophys. Res. Commun.
218,
813-821[CrossRef][Medline]
[Order article via Infotrieve]
32.
Crider, B. P.,
Andersen, P.,
White, A. E.,
Zhou, Z.,
Li, X.,
Mattsson, J. P.,
Lundberg, L.,
Keeling, D. J.,
Xie, X.-S.,
Stone, D. K.,
and Peng, S.-B.
(1997)
J. Biol. Chem.
272,
10721-10728 33.
Zhou, Z.,
Peng, S.-B.,
Crider, B. P.,
Slaughter, C.,
Xie, X.-S.,
and Stone, D. K.
(1998)
J. Biol. Chem.
273,
5878-5884 34.
Peng, S.-B.,
Li, X.,
Crider, B. P.,
Zhou, Z.,
Andersen, P.,
Tsai, S. J.,
Xie, X.-S.,
and Stone, D. K.
(1999)
J. Biol. Chem.
274,
2549-2555 35.
Karet, F. E.,
Finberg, K. E.,
Nelson, R. D.,
Nayir, A.,
Mocan, H.,
Sanjad, S. A.,
Rodriguez-Soriano, J.,
Santos, F.,
Cremers, C. W.,
Di Pietro, A.,
Hoffbrand, B. I.,
Winiarski, J.,
Bakkaloglu, A.,
Ozen, S.,
Dusunsel, R.,
Goodyer, P.,
Hulton, S. A.,
Wu, D. K.,
Skvorak, A. B.,
Morton, C. C.,
Cunningham, M. J.,
Jha, V.,
and Lifton, R. P.
(1999)
Nat. Genet.
21,
84-90[CrossRef][Medline]
[Order article via Infotrieve]
36.
Takahashi, N.,
Akatsu, T.,
Sasaki, T.,
Nicholson, G. C.,
Moseley, J. M.,
Martin, T. J.,
and Suda, T.
(1988)
Endocrinology
123,
1504-1510[Abstract]
37.
Yamashita, T.,
Asano, K.,
Takahashi, N.,
Akatsu, T.,
Udagawa, N.,
Sasaki, T.,
Martin, T. J.,
and Suda, T.
(1990)
J. Cell. Physiol.
145,
587-595[CrossRef][Medline]
[Order article via Infotrieve]
38.
Kyte, J.,
and Doolittle, R. F.
(1982)
J. Mol. Biol.
157,
105-132[CrossRef][Medline]
[Order article via Infotrieve]
39.
Leng, X.-H.,
Nishi, T.,
and Forgac, M.
(1999)
J. Biol. Chem.
274,
14655-14661 40.
Perin, M. S.,
Fried, V. A.,
Stone, D. K.,
Xie, X.-S.,
and Südhof, T. C.
(1991)
J. Biol. Chem.
266,
3877-3881 41.
Lee, B. S.,
Holliday, L. S.,
Ojikutu, B.,
Krits, I.,
and Gluck, S. L.
(1996)
Am. J. Physiol.
270,
382-388
42.
Mattsson, J. P.,
Skyman, C.,
Palokangas, H.,
Väänänen, K. H.,
and Keeling, D. J.
(1997)
J. Bone Miner. Res.
12,
753-760[CrossRef][Medline]
[Order article via Infotrieve]
43.
Higuchi, Y.,
Ito, M.,
Tajima, M.,
Higuchi, S.,
Miyamoto, N.,
Nishio, M.,
Kawano, M.,
Kusagawa, S.,
Tsurudome, M.,
Sudo, A.,
Katou, K.,
Uchida, A.,
and Ito, Y.
(1999)
Bone
25,
17-24[Medline]
[Order article via Infotrieve]
44.
Abu-Amer, Y.,
Ross, F. P.,
Schlesinger, P.,
Tondravi, M. M.,
and Teitelbaum, S. L.
(1997)
J. Cell Biol.
137,
247-258 45.
Hirokawa, N.
(1998)
Science
279,
519-526
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. Feng, T. Cheng, N. J. Pavlos, K. H. M. Yip, A. Carrello, R. Seeber, K. Eidne, M. H. Zheng, and J. Xu Cytoplasmic Terminus of Vacuolar Type Proton Pump Accessory Subunit Ac45 Is Required for Proper Interaction with V0 Domain Subunits and Efficient Osteoclastic Bone Resorption J. Biol. Chem., May 9, 2008; 283(19): 13194 - 13204. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Da Silva, W. W. C. Shum, J. El-Annan, T. G. Paunescu, M. McKee, P. J. S. Smith, D. Brown, and S. Breton Relocalization of the V-ATPase B2 subunit to the apical membrane of epididymal clear cells of mice deficient in the B1 subunit Am J Physiol Cell Physiol, July 1, 2007; 293(1): C199 - C210. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Johansson, T. J. de Vries, T. Schoenmaker, M. Ehinger, A. C. M. Brun, A. Fasth, S. Karlsson, V. Everts, and J. Richter Hematopoietic stem cell-targeted neonatal gene therapy reverses lethally progressive osteopetrosis in oc/oc mice Blood, June 15, 2007; 109(12): 5178 - 5185. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Breton and D. Brown New insights into the regulation of V-ATPase-dependent proton secretion Am J Physiol Renal Physiol, January 1, 2007; 292(1): F1 - F10. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-H. Sun-Wada, T. Toyomura, Y. Murata, A. Yamamoto, M. Futai, and Y. Wada The a3 isoform of V-ATPase regulates insulin secretion from pancreatic {beta}-cells J. Cell Sci., November 1, 2006; 119(21): 4531 - 4540. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Edwards, C. Cohen, W. Xu, and P. H. Schlesinger c-Src Control of Chloride Channel Support for Osteoclast HCl Transport and Bone Resorption J. Biol. Chem., September 22, 2006; 281(38): 28011 - 28022. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Poea-Guyon, M. Amar, P. Fossier, and N. Morel Alternative Splicing Controls Neuronal Expression of v-ATPase Subunit a1 and Sorting to Nerve Terminals J. Biol. Chem., June 23, 2006; 281(25): 17164 - 17172. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dettmer, A. Hong-Hermesdorf, Y.-D. Stierhof, and K. Schumacher Vacuolar H+-ATPase Activity Is Required for Endocytic and Secretory Trafficking in Arabidopsis PLANT CELL, March 1, 2006; 18(3): 715 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Beyenbach and H. Wieczorek The V-type H+ ATPase: molecular structure and function, physiological roles and regulation J. Exp. Biol., February 15, 2006; 209(4): 577 - 589. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wassmer, R. Kissmehl, J. Cohen, and H. Plattner Seventeen a-Subunit Isoforms of Paramecium V-ATPase Provide High Specialization in Localization and Function Mol. Biol. Cell, February 1, 2006; 17(2): 917 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pietrement, G-H. Sun-Wada, N. D. Silva, M. McKee, V. Marshansky, D. Brown, M. Futai, and S. Breton Distinct Expression Patterns of Different Subunit Isoforms of the V-ATPase in the Rat Epididymis Biol Reprod, January 1, 2006; 74(1): 185 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Smith, F. Jouret, S. Bord, K. J. Borthwick, R. S. Al-Lamki, C. A. Wagner, D. C. Ireland, V. Cormier-Daire, A. Frattini, A. Villa, et al. Vacuolar H+-ATPase d2 Subunit: Molecular Characterization, Developmental Regulation, and Localization to Specialized Proton Pumps in Kidney and Bone J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1245 - 1256. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Beaulieu, N. Da Silva, N. Pastor-Soler, C. R. Brown, P. J. S. Smith, D. Brown, and S. Breton Modulation of the Actin Cytoskeleton via Gelsolin Regulates Vacuolar H+-ATPase Recycling J. Biol. Chem., March 4, 2005; 280(9): 8452 - 8463. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Wagner, K. E. Finberg, S. Breton, V. Marshansky, D. Brown, and J. P. Geibel Renal Vacuolar H+-ATPase Physiol Rev, October 1, 2004; 84(4): 1263 - 1314. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Derks and K. D. Beaman Regeneration and Tolerance Factor Prevents Bystander T-Cell Death Associated with Human Immunodeficiency Virus Infection Clin. Vaccine Immunol., September 1, 2004; 11(5): 835 - 840. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lu, Y. Y. Sautin, L. S. Holliday, and S. L. Gluck The Glycolytic Enzyme Aldolase Mediates Assembly, Expression, and Activity of Vacuolar H+-ATPase J. Biol. Chem., March 5, 2004; 279(10): 8732 - 8739. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Chen, M. R. Bubb, E. G. Yarmola, J. Zuo, J. Jiang, B. S. Lee, M. Lu, S. L. Gluck, I. R. Hurst, and L. S. Holliday Vacuolar H+-ATPase Binding to Microfilaments: REGULATION IN RESPONSE TO PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY AND DETAILED CHARACTERIZATION OF THE ACTIN-BINDING SITE IN SUBUNIT B J. Biol. Chem., February 27, 2004; 279(9): 7988 - 7998. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Manolson, H. Yu, W. Chen, Y. Yao, K. Li, R. L. Lees, and J. N. M. Heersche The a3 Isoform of the 100-kDa V-ATPase Subunit Is Highly but Differentially Expressed in Large ("=" BORDER="0">10 Nuclei) and Small ( [Abstract]
[Full Text]
[PDF]
|
||||
|
|